Mobile Health (mHealth) Device Market Report 2026

The mobile health (mhealth) device market size has grown rapidly in recent years. It will grow from $53.05 billion in 2025 to $60.73 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to rise in fitness tracker adoption, early smartwatch health features, growth in telehealth services, increase in chronic disease cases, expansion of mobile health apps.

The mobile health (mhealth) device market size is expected to see rapid growth in the next few years. It will grow to $105.17 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to growth in remote patient monitoring, rising demand for preventive care, expansion of connected care models, higher consumer health awareness, integration with digital health platforms. Major trends in the forecast period include wearable vital sign tracking devices, multi sensor health smartwatches, connected home diagnostic kits, continuous remote health monitoring, app integrated medical wearables.

The expansion of remote patient monitoring is expected to fuel growth in the mHealth devices market in the future. Remote patient monitoring involves the use of connected medical devices and digital technologies to continuously gather, transmit, and analyze patient health data outside traditional healthcare environments, supporting timely clinical decisions and improved outcomes. Its adoption is rising due to the growing use of digital health technologies that enable continuous, real-time patient tracking beyond conventional clinical settings. mHealth devices facilitate remote patient monitoring by allowing constant data collection and real-time transmission of health information, enabling healthcare providers to monitor conditions remotely, deliver timely interventions, and enhance overall care efficiency. For example, in August 2025, according to the U.S. Department of Health & Human Services (OIG), a US-based government agency, Medicare reimbursement for remote patient monitoring (RPM) exceeded US$536 million in 2024, marking a 31% year-over-year increase. Nearly one million beneficiaries used RPM services, a 27% rise compared to 2023, while approximately 4,600 medical practices regularly submitted RPM billing claims. Consequently, the growth of remote patient monitoring is expected to drive the mHealth devices market.

Key companies operating in the mHealth devices market are focusing on developing innovative solutions, such as advanced wearable health monitoring devices, to meet the rising demand for remote patient monitoring, preventive healthcare, and real-time health data analytics driven by increasing chronic disease prevalence and consumer wellness awareness. Advanced wearable health monitoring devices typically include a suite of sensors that continuously collect physiological data and transmit it via connected mobile apps or cloud services, enabling users and healthcare providers to monitor health outside traditional clinical settings; unlike traditional intermittent check-ups or standalone medical devices, these wearables facilitate 24/7 data capture, trend analysis, and proactive health interventions. For example, in May 2025, WHOOP Inc., a US-based wearable technology company, launched WHOOP 5 and WHOOP MG, a next-generation wearable health and fitness platform that combines an extended 14+ day battery life, advanced sensors for sleep, recovery, strain, and stress tracking, and new blood pressure insights and on-demand ECG heart screening through the WHOOP MG variant, providing continuous healthspan and cardiovascular monitoring beyond typical consumer fitness trackers; the devices are designed as a slim, screen-free strap worn 24/7 with data delivered through the companion app, offering deeper health analytics and personalized recommendations to optimize performance and wellness.

In August 2025, Ultrahuman Healthcare Pvt Ltd., an India-based health-tech wearable and metabolic fitness company, acquired viO HealthTech for an undisclosed sum. With this acquisition, Ultrahuman plans to broaden its range of sensor-driven health monitoring devices and enhance its expertise in women’s health tracking by incorporating advanced ovulation sensing technology and predictive algorithms into its wearable ecosystem. viO HealthTech Limited is an India-based company focused on developing non-invasive ovulation tracking sensors and intelligent reproductive health analytics that deliver accurate, real-time fertility insights to users.

Major companies operating in the mobile health (mhealth) device market are Apple Inc., Google LLC, Samsung Electronics Co. Ltd., Abbott Laboratories, Koninklijke Philips N.V., Garmin Health Inc., OMRON Healthcare Inc., ResMed Inc., Garmin Ltd., DexCom Inc., Masimo Corporation, iRhythm Technologies Inc., BioTelemetry Inc., Biofourmis Pte. Ltd., Withings S.A.S., BPL Medical Technologies Private Limited, AliveCor Inc., iHealth Labs Inc., WellDoc Inc., Qardio Inc.

Tariffs on wearable electronics, biosensors, communication modules, and semiconductor components are impacting the mobile health devices market by increasing device manufacturing costs. Hardware heavy segments such as smartwatches, glucose monitors, and portable diagnostic kits are most affected, particularly where production depends on asia pacific electronics supply chains. Higher import duties can raise retail prices and slow adoption in cost sensitive regions. However, tariffs are also encouraging localized assembly and regional component sourcing strategies. This supports domestic device makers and regional digital health hardware ecosystems.

The mobile health (mhealth) device market research report is one of a series of new reports that provides mobile health (mhealth) device market statistics, including mobile health (mhealth) device industry global market size, regional shares, competitors with a mobile health (mhealth) device market share, detailed mobile health (mhealth) device market segments, market trends and opportunities, and any further data you may need to thrive in the mobile health (mhealth) device industry. This mobile health (mhealth) device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Mobile health (mHealth) devices are portable and wearable medical or health-monitoring instruments that collect, track, and transmit health-related data in real time. They are designed to support continuous health observation, facilitate early detection of medical issues, and provide users and healthcare professionals with actionable insights. Additionally, they enable remote patient management, personalized care, and greater engagement in wellness and disease management programs.

The principal product types of mobile health (mHealth) devices include blood pressure monitors, blood glucose meters, pulse oximeters, neurological monitors, heart rate meters, electrocardiogram monitors, cardiac monitors, peak flow meters, multiparameter trackers, smartwatches such as Fitbit, sleep apnea meters, and other related devices. Blood pressure monitors are devices that measure and track blood pressure to aid in the management of hypertension and other cardiovascular conditions. These devices leverage technologies such as Bluetooth and Bluetooth Low Energy, Wi-Fi, cellular (4G or 5G), near-field communication, and radio frequency identification. Applications include chronic care management, diabetes management, cancer management, general health, fitness, mental health and behavioral disorder management, blood pressure monitoring, nutrition tracking, medical management, women’s health, and other applications, with end users including home healthcare providers, hospitals, diagnostic laboratories, clinics, and academic research institutions.

The mobile health (mHealth) devices market consists of sales of wearable health trackers, smartwatches with health monitoring features, mobile-connected blood pressure monitors, fitness bands, smart thermometers, portable diagnostic devices, and telemedicine kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.